Oestrogen/growth factor cross-talk in breast carcinoma: A specific target for novel antioestrogens

Trends in Pharmacological Sciences

Volumn 18, Issue 7, 1997, Pages 245-251

  De Cupis, Alessandra ^a   Favoni, Roberto E ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; BASIC FIBROBLAST GROWTH FACTOR; CATHEPSIN; CATHEPSIN D; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FULVESTRANT; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; TAMOXIFEN; TOREMIFENE; TRANSFORMING GROWTH FACTOR;

BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030749581     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(97)01083-3     Document Type: Review

References (69)

1. Reynolds, P. et al. (1994) Cancer Epidemiol. Biomarkers Prev. 3, 253-259
2. Miller, A. B. and Bulbrook, R. D. (1986) Int. J. Cancer 37, 173-177
3. Newcomb, P. A. and Lantz, P. M. (1993) Breast Cancer Res. Treat. 28, 97-106
4. Clarke, R. et al. (1993) Breast Cancer Res. Treat. 24, 227-239
5. Osborne, C. K. and Arteaga, C. L. (1990) Breast Cancer Res. Treat. 15, 3-11
6. Strobl, J. S., Wonderlin, W. F. and Flynn, D. C. (1995) Gen. Pharmacol. 26, 1643-1649
7. Jordan, V. C. (1995) Breast Cancer Res. Treat. 36, 267-289
8. Landel, L. L., Rushner, P. J. and Greene, G. L. (1994) Mol. Endocrinol. 8, 1407-1419
9. Parker, M. G., Arbuckle, N., Dauvois, S., Danielian, P. and White, R. (1993) Ann. New York Acad. Sci. 684, 119-126
10. Ruh, M. F., Cox, L. K. and Ruh, T. S. (1996) Biochem. Pharmacol. 52, 869-878
11. Parker, M. G. (1993) Breast Cancer Res. Treat. 26, 131-137
12. Danielian, P. S., White, R., Lees, J. A. and Parker, M. G. (1992) EMBO J. 11, 1025-1033
13. Baselga, J., Mendelsohn, J., Kim, Y. M. and Pandiella, A. (1996) J. Biol. Chem. 271, 3279-3284
14. Fynan, T. M. and Reiss, M. (1993) Crit. Rev. Oncogen. 4, 493-540
15. MacCallum, J. et al. (1994) Br. J. Cancer 69, 1008-1009
16. Lin, H. Y. and Moustakas, A. (1994) Cell. Mol. Biol. 40, 337-349
17. Westley, B. and Rochefort, H. (1980) Cell 20, 353-362
18. Long, B. J., Hendrik, W. and van der Berg, H. (1996) Cancer Lett. 99, 233-238
19. Boonstra, J. et al. (1995) Cell. Biol. Int. 19, 413-430
20. McLeskey, S. W. et al (1996) Breast Cancer Res. Treat. 39, 103-117
21. Muenke, M. and Schell, U. (1995) Trends Genet. 11, 308-313
22. Claesson-Welsh, L. (1994) Prog. Growth factor Res. 5, 37-54
23. Bronzert, D. A. et al. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 5763-5767
24. Seymour, L. and Bezwoda, W. R. (1994) Breast Cancer Res. Treat. 32, 229-233
25. Stewart, A. J., Johnson, M. D., May, F. E. B. and Westley, B. R. (1990) J. Biol. Chem. 265, 21172-21178
26. Huynh, H., Yang, X. and Pollak, M. (1996) J. Biol. Chem. 271, 1016-1021
27. Lee, A. V. and Yee, D. (1995) Biomed. Pharmacother. 49, 415-421
28. Papa, V. et al. (1993) Cancer Res. 53, 3763-3740
29. Minuto, P. et al. (1988) Cancer Res. 48, 3716-3719
30. Quinn, K. A. et al. (1996) J. Biol. Chem. 271, 11477-11483
31. Yee, D. et al. (1989) Mol. Endocrinol. 3, 509-517
32. Yee, D., Rosen, N., Favoni, R. E. and Cullen, K. J. (1991) in Regulatory Mechanisms in Breast Cancer (Lippman, M. E. and Dickson, R. B., eds), pp. 93-106, Kluwer Academic
33. Dickson, R. B., Shi, Y. E. and Johnson, M. D. (1994) Breast Cancer Res. Treat. 31, 167-173
34. Rochefort, H. (1994) Eur. J. Cancer 30A, 1583-1586
35. Martinez-Lacaci, I. and Dickson, R. B. (1996) J. Steroid. Biochem. Mol. Biol. 57, 1-11
36. Safarians, S., Sternlicht, M. D., Yamanishi, D. T., Love, S. M. and Barsky, S. H. (1996) Cancer Res. 56, 3560-3569
37. Stewart, A. J., Westley, B. R. and May, F. E. B. (1992) Br. J. Cancer 66, 640-648
38. de Cupis, A. et al. (1995) Br. J. Pharmacol. 116, 2391-2400
39. Pratt, S. E. and Pollak, M. N. (1993) Cancer Res. 53, 5193-5198
40. Knabbe, C. et al. (1987) Cell 48, 417-428
41. Arrick, B. A., Korc, M. and Derynck, R. (1990) Cancer Res. 50, 299-303
42. Beatson, G. T. (1896) Lancet ii, 104-107
43. Nicholson, R. I., Eaton, C. L. and Mannining, D. L. (1992) in Recent Advances in Endocrinology and Metabolism (Edwards, C. and Lincoln, D., eds), pp. 151-165, Churchill Livingstone
44. Jaiyesimi, I. A., Buzdar, A. U., Decker, D. A. and Hortobagyi, G. N. (1995) J. Clin. Oncol. 13, 513-529
45. Smith, L. L. and White, I. N. (1995) Toxicol. Lett. 82-83, 181-186
46. Jordan, V. C. (1995) Ann. New York Acad. Sci. 768, 141-147
47. Colletta, A. A., Benson, J. R. and Baum, M. (1994) Breast Cancer Res. Treat. 31, 5-9
48. Perry, R. R., Kang, Y. and Greaves, B. (1995) Ann. Surg. Oncol. 2, 238-245
49. Berthois, Y., Dong, X. F. and Martin, P. M. (1989) Biochem. Biophys. Res. Commun. 159, 126-131
50. Freiss, G., Rochefort, H. and Vignon, F. (1990) Biochem. Biophys. Res. Commun. 173, 919-926
51. Huynh, H. and Pollack, M. (1994) Biochem. Biophys. Res. Commun. 203, 253-259
52. Huynh, H., Tetenes, E., Wallace, L. and Pollak, M. (1993) Cancer Res. 53, 1727-1730
53. Osborne, C. K., Wiebe, V. J., McGuire, W. L., Ciocca, D. R. and DeGregorio, M. W. (1992) J. Clin. Oncol. 10, 304-310
54. Tonetti, D. A. and Jordan, V. C. (1995) Anti-Cancer Drugs 9, 498-507
55. Wolf, D. M., Langan-Fahey, M., Parker, C. J., McCague, R. and Jordan, V. C. (1993) J. Natl. Cancer Inst. 85, 806-812
56. Pavlik, E. J. et al. (1992) Cancer Res. 52, 4106-4112
57. Gadishar, W. J. and Jordan, V. C. (1997) J. Clin. Oncol. 15, 840-852
58. Johnston, S. R. D. et al. (1997) Br. J. Cancer 75, 804-809
59. Bowler, J., Pittarn, J. D. and Wakeling, A. E. (1988) Steroids 54, 71-99
60. Wakeling, A. E. (1990) J. Steroid Biochem. Mol. Biol. 37, 771-775
61. Wakeling, A. E. (1993) Breast Cancer Res. Treat. 25, 1-9
62. Wakeling, A. E. (1992) Cancer Surveys 14, 71-85
63. Wakeling, A. E. and Bowler, J. (1988) J. Steroid Biochem. 31, 645-653
64. Wakeling, A. E., Dukes, M. and Bowler, J. (1991) Cancer Res. 51, 3867-3873
65. Gottardis, M. M., Jiang, S. Y., Jeng, M. H. and Jordan, V. C. (1989) Cancer Res. 49, 4090-4093
66. Brunner, N. et al. (1993) Cancer Res. 53, 3229-3232
67. DeFriend, D. J. et al. (1994) Br. J. Cancer 70, 204-211
68. DeFriend, D. J. et al. (1994) Cancer Res. 54, 408-414
69. Howell, A., DeFriend, D., Robertson, J., Blamey, R. and Walton, P. (1995) Lancet 345, 29-30